Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFT New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Wellmune enters fruit chews: Immune health firm Biothera provides its Wellmune WGP ingredient for citrus and pom-blueberry fruit chews in the Dr. Sears Family Essentials line of supplements and snacks. At the Institute of Food Technologists Food Expo July 18 in Chicago, Biothera Communications VP David Walsh said the Eagan, Minn.-based firm continues seeking food, beverage and supplement applications for Wellmune, a gluco polysaccharide derived from a proprietary yeast strain. "If it's in a product, it has to be in a product that's consumed on a regular - if not daily - basis, so you can continue to prime these [immune] cells so you get the immune benefits," Walsh said in an interview. Biothera received a letter of "no objection" from FDA regarding Wellmune's generally recognized as safe status. Walsh added Wellmune's "pipeline is full" of forthcoming applications and results of recent studies on the ingredient's efficacy are expected this year

You may also be interested in...



Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden

Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.

Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden

Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.

Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden

Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel